DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Morepen Laboratories Limited — Outcome of Board Meeting

NSE 1 hr ago·27 Oct 2026, 8:01 am

Morepen Laboratories

Morepen Laboratories has informed the stock exchanges that its board has approved the financial results for the period ending September 30, 2026. This announcement signals the completion of the company's internal review and audit processes for the quarter.

For investors, this update is crucial as it provides the first official data point regarding the company's performance during this period. It allows stakeholders to assess the firm's operational health and financial trajectory ahead of the broader market commentary.

Investors should watch for the detailed financial statements, which will reveal revenue growth, profit margins, and cash flow. Monitoring the management commentary on future guidance will also be key to understanding the company's strategic outlook.